The Global Healthy Living Foundation (GHLF) recently published a policy paper authored by Robert Popovian, PharmD, MS, Founder, Conquest Advisors and GHLF’s Chief Science Policy Officer, “Challenges ...

In a recent conversation with Greg Baker, CEO of AffirmedRx, the PBM professional outlined the company’s distinct approach in the PBM industry with MHE editors. In a recent conversation with Greg ...

India now has the physical and digital infrastructure to raise the share of the manufacturing sector in the economy and make a realistic bid to be an important player in global supply chains. A ...

New regulations from New York's financial industry monitor—aimed at leveling the playing field for independent pharmacies by incorporating a series of market conduct rules for pharmacy benefit ...

The report titled 'Global Trade in Flux: Politics, Policy, and the Reconfiguration of Supply Chains' published in November offers insights from Citi’s experts around the world on how the very nature ...

From design, development and launching of smart products to engineering agile and sustainable manufacturing operations, at HCLTech, we work together to improve your productivity, bring cost ...

As a pharmacist for more than 30 years and now the CEO of a transparent pharmacy benefit manager (PBM), I've witnessed the devastating impact of our broken prescription drug system from every angle.

Do not expect the Trump Administration to forget.” Paragon is currently lobbying against PBM reform, which would fix misaligned incentives to make drugs more affordable for the average American.

Corning is investing $900 million in a solar wafer manufacturing plant — one-fourth of which could be eligible for CHIPS Act taxpayer subsidies. This is the new supply chain that will make ...

Dennis O'Reilly brings a unique perspective to his work evaluating tech products for small businesses. He combines years of experience in tech publishing for PC World, Windows Secrets and other ...

Delivery of a critically important air handling unit was pushed back nearly six months due to both a slow supply chain and a slight unit modification requested by the owner that unexpectedly reset ...

As of October 9, the FDA announced the temporary importation of 19 different IV solution and dialysis products from 5 different international manufacturing plans to bolster domestic supply.